
    
      Randomized study with five groups to receive one of the following vaccination regimens: One
      of the three formulations of GSK Biologicals' Hib-MenAC mixed with GSK Biologicals'
      Tritanrix™-HepB (3 different groups) GSK Biologicals' Tritanrix™-HepB + GSK Biologicals'
      Hiberix™ GSK Biologicals' Tritanrix™-HepB mixed with GSK Biologicals' Hiberix™ + Wyeth
      Lederle's Meningitec™
    
  